These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 348087)

  • 21. Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphoma.
    Takasugi BJ; Jones SE; Robertone AB
    Cancer Treat Rep; 1984 Nov; 68(11):1399-401. PubMed ID: 6498855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.
    Van Amburg AL; Presant CA; Vélez-García E; Klahr C
    Cancer Treat Rep; 1979 Jan; 63(1):141-2. PubMed ID: 105806
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of F-leurosine (formyl-leurosine) on platelet production in mice.
    Krizsa F; Cserháti I
    Haematologia (Budap); 1977; 11(1-2):149-54. PubMed ID: 615086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current trends in the chemotherapy of cancer].
    Silva-Sosa M
    Gac Med Mex; 1974 May; 107(5):469-87. PubMed ID: 4602758
    [No Abstract]   [Full Text] [Related]  

  • 25. Mitolactol chemotherapy for malignant melanoma: a phase II study.
    Malden LT; Coates AS; Milton GW; McCarthy WH; Levi JA; Woods RL; Byrne MJ; Reynolds PM; Fox RM; Hedley DW
    Cancer Treat Rep; 1984; 68(7-8):1045-6. PubMed ID: 6744338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EC-145, a folate-targeted Vinca alkaloid conjugate for the potential treatment of folate receptor-expressing cancers.
    Dosio F; Milla P; Cattel L
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1424-33. PubMed ID: 21154124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic pattern of formyl-leurosine induced acute cardiovascular depression in the dog.
    Juhász-Nagy A; Sótonyi P; Bertók L
    Acta Chir Hung; 1985; 26(1):35-49. PubMed ID: 4002970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials with leurosine methiodide, an alkaloid from Vinca rosea Linn.
    HODES ME; ROHN RJ; BOND WH; YARDLEY J
    Cancer Chemother Rep; 1963 Apr; 28():53-5. PubMed ID: 13963767
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacology and use of microtubule-targeting agents in cancer therapy.
    Zelnak AB
    Methods Mol Med; 2007; 137():209-34. PubMed ID: 18085232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New antitumor derivatives of vinblastine].
    Bölcskei H; Szántay C; Mák M; Balázs M; Szántay C
    Acta Pharm Hung; 1998 Mar; 68(2):87-93. PubMed ID: 9592933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550).
    Colevas AD; West PJ; Cheson BD
    Oncology (Williston Park); 2001 Sep; 15(9):1168-9, 1172-5. PubMed ID: 11589064
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
    Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
    Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II study of mitolactol in chemotherapy-refractory metastatic breast cancer.
    Creech RH; Catalano RB; Dierks KM; Shah MK
    Cancer Treat Rep; 1984 Dec; 68(12):1499-501. PubMed ID: 6548936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; McGehee R; Barrett RJ
    J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methyl-CCNU and ftorafur in treatment of rectosigmoidal tumors and ftorafur capsules in treatment of colorectal tumors.
    Mechl Z; Malír
    Recent Results Cancer Res; 1981; 79():59-64. PubMed ID: 6795699
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 37. Complex evaluation of the effect of some cytostatic hexitol derivatives.
    Holczinger L; Somfai-Relle S; Institoris E; Gáti E; Turi G
    Oncology; 1980; 37 Suppl 1():104-8. PubMed ID: 7454197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 20th-century advances in drug therapy in oncology--Part. II.
    Dutcher JP; Novik Y; O'Boyle K; Marcoullis G; Secco C; Wiernik PH
    J Clin Pharmacol; 2000 Oct; 40(10):1079-92. PubMed ID: 11028247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotoxicity in cancer chemotherapy: vinca alkaloids.
    Lobert S
    Crit Care Nurse; 1997 Aug; 17(4):71-9. PubMed ID: 9325775
    [No Abstract]   [Full Text] [Related]  

  • 40. STUDIES ON CATHARANTHUS LANCEUS (VINCA LANCEA). I. ISOLATION OF LEUROSINE, PERIVINE, AND YOHIMBINE.
    FARNSWORTH NR; LOUB WD; BLOMSTER RN
    J Pharm Sci; 1963 Nov; 52():1114. PubMed ID: 14079649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.